Publications Office of the EU
Sag T-174/22: Sag anlagt den 4. april 2022 — Novartis mod EUIPO — AstraZeneca (BREZTREV)
DisplayCustomHeader
Webindholdsvisning
Publication Detail Actions Portlet
custom-survey-notification
Publication Detail Portlet

Publication detail

Home
Publication Viewer

Dokumentvisning

Pop up window annotations